Revolutionizing Pancreatic Cancer: Immunology and Therapy Breakthroughs
Pancreatic cancer remains one of the most aggressive malignancies globally, with a historically poor prognosis and limited therapeutic options. Recent ...
Pancreatic cancer remains one of the most aggressive malignancies globally, with a historically poor prognosis and limited therapeutic options. Recent ...
In a groundbreaking study, a team of researchers led by Hao et al. presents a remarkable investigation into the heterogeneity ...
In an extraordinary study destined to reshape our understanding of tumor immunology, researchers have unveiled the mechanisms by which senescent ...
In a groundbreaking study published in BMC Cancer, researchers have unveiled the pivotal role of Discoidin Domain Receptor 1 (DDR1) ...
Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with limited therapeutic options and a poor prognosis that continues ...
In the shadowy microenvironment of pancreatic cancer, a new frontier is emerging that bridges the nervous system and tumor biology ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine